Search results
CRISPR can treat common form of inherited blindness, early data hint
Live Science via Yahoo News· 4 weeks agoA photo shows two male doctors in surgery garb as one preps a long needle for a procedure. A patient...
Is CRISPR Therapeutics Stock a Buy?
Motley Fool via Yahoo Finance· 3 weeks agoCRISPR Therapeutics (NASDAQ: CRSP) is a star in the gene-editing therapy niche. The company made tremendous progress over the past few years, culminating...
2023 was a big year for CRISPR-based gene editing but challenges remain
Engadget· 6 months ago2023 was an important year for patients with sickle cell disease. The FDA approved Vertex’s...
Experimental gene therapy restores some vision in patients with inherited blindness
CNN via Yahoo News· 1 month agoFor her entire life, college student Olivia Cook had only a small degree of central vision. It was...
A Comprehensive Guide to Genomic ETFs
Zacks via Yahoo Finance· 2 years agoThe gene therapeutics space is witnessing growth worldwide amid a surge in several types of genetic disorders like hemophilia and thalassemia. Genome...
Gene therapy might cure sickle cell, but at a steep cost for patients, society
USA TODAY via Yahoo News· 7 months agoMyles Newsome has spent as many school days in the hospital as he has at his high school. In middle...
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
InvestorPlace via Yahoo Finance· 1 month agoPay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market...
"The Era of the Gene-Edited Human Is Here"
Motley Fool· 2 years agoHow investors can approach investing in gene therapies. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. Karl...
Gene therapy: Everything you need to know about the DNA-tweaking treatments
Live Science via Yahoo News· 1 year agoConcept of gene editing. Here we see a gloved hand with tweezers pinching out a part of a DNA double...
Death in US gene therapy study sparks search for answers
Associated Press via Yahoo News· 2 years agoTerry Horgan, a 27-year-old who had Duchenne muscular dystrophy, died last month, according to Cure Rare Disease, a Connecticut-based nonprofit founded by his brother, Rich, to try and save ...
